Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists
ConclusionsThis retrospective observational study found a similar efficacy between DOAC and VKA agents in patients with LV thrombi (70.6% vs. 71.5%); however, when the thrombus remains, VKAs are still the standard of care as it is possible to control INR levels (3 –4) with them.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Arrhythmia | Cardiology | Cardiomyopathy | Drugs & Pharmacology | Heart | Heart Attack | Heart Failure | Ischemic Stroke | Pain | Pain Management | Stroke | Study | Thrombosis | Vitamin K | Vitamins | Women